Bessemer Group
TMDI

Bessemer Group’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bessemer Group’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,217
Closed -$9K – 2087
2018
Q3 		$9K Buy
+4,217
New +$11.9K ﹤0.01% 1619

Other funds holding TMDI

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PI
Pathlight Investors Phoenix, Arizona $121M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
SHA
Seneca House Advisors Richmond, Virginia $252M AUM 17.04% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Bessemer Group's TMDI Position: Q4 2018 in Review

Bessemer Group sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q4 2018, closing a stake of 4,217 shares — an estimated $9K sold.

Bessemer Group first reported a position in TMDI in Q3 2018 and held it in 1 quarter. The position peaked at $9K in Q3 2018. 43 funds tracked by Wall St. Rank hold TMDI as of Q4 2018.

  • Bessemer Group reported no remaining Titan Medical Inc. Ordinary Shares position as of Q4 2018 after selling out during the quarter.
  • Bessemer Group sold 4,217 Titan Medical Inc. Ordinary Shares shares in Q4 2018, an estimated $9K.
  • Bessemer Group first reported a position in Titan Medical Inc. Ordinary Shares in Q3 2018 and held it in 1 quarter.
  • Bessemer Group's Titan Medical Inc. Ordinary Shares position peaked at $9K in Q3 2018.
  • 43 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q4 2018.

Based on Bessemer Group's 13F filing for Q4 2018, filed 12 Feb 2019.